SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Statement

19 May 2008 13:30

RNS Number : 7780U
Flomerics Group PLC
19 May 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATESAUSTRALIACANADA OR JAPAN

FOR IMMEDIATE RELEASE

19th May 2008

FLOMERICS GROUP PLC

Statement re: Posting of Offer Document following Unsolicited Offer

 

 

The Board of Directors of Flomerics Group PLC ("Flomerics" or the "Company") notes the statement by Mentor Graphics, Inc. ("Mentor") that it has posted an offer document to Flomerics shareholders in respect of its unsolicited offer for all the outstanding shares and stock options in Flomerics at a price of 104 pence per share payable in cash (the "Offer"). 

 

The Board of Directors of Flomerics continues to believe the Offer materially undervalues the Company and is actively engaged in assessing other alternatives available to the Company, including potential interest expressed by a number of other parties, which are the subject of ongoing discussions. Shareholders are therefore strongly urged to ignore any documents or announcements that may be made or issued by Mentor or its advisers and not to sell their valuable Flomerics shares.

David Mann, Chairman of Flomerics commented: "We have previously stated that the Offer, which is unsolicited, has been considered by the Board of Flomerics, in conjunction with its independent adviser, and we have unanimously concluded that it does not reflect the true value of Flomerics shares. As such, the Offer does not carry the recommendation of the Flomerics Board of Directors as we do not believe it is in the best interests of Flomerics shareholders." 

The Board of Directors intends to write to its shareholders in due course to explain its current position with regard to the Mentor Offer.

Any discussions with other interested parties continue to be at an early stage and there can be no certainty that an alternative offer will be forthcoming. However, shareholders are strongly recommended to take no action at this stage. A further announcement will be made in due course.

 

Enquiries: 

 

Flomerics Group PLC

Gary Carter

Keith Butcher

Tel: 020 8487 3000

Jefferies International Ltd (Financial adviser to Flomerics)

Andres Pieczanski

Sarah McNicholas

Tel: 020 7029 8000

Oriel Securities Limited (Nominated Adviser and Corporate Broker to Flomerics)

Andrew Edwards

Michael Shaw

Tel: 020 7710 7600

Citigate Dewe Rogerson

Ginny Pulbrook

Seb Hoyle

Tel: 020 7638 9571

 

Jefferies International Limited ("Jefferies International"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Jefferies International or for giving advice in relation to such matters.

Oriel Securities Limited ("Oriel Securities"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Oriel Securities or for giving advice in relation to such matters.

 

 Dealing Disclosure Requirements 

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Flomerics, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Nestor, they will be deemed to be a single person for the purpose of Rule 8.3. 

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Flomerics by a potential offeror or by Flomerics, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction. 

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

 

Terms in quotation marks are defined in the Code, which can also be found on the Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPGUUAPAUPRGPB
Date   Source Headline
10th Jul 20177:00 amRNSAcquisition of Orange County Ltd, County Durham
7th Jul 201712:26 pmRNSHolding(s) in Company
23rd Jun 20177:00 amRNSFlowtech adds technical expertise & product
26th May 20171:34 pmRNSHolding(s) in Company
25th May 201711:34 amRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
22nd May 201712:45 pmRNSIssue of Equity
8th May 20175:11 pmRNSHolding(s) in Company
26th Apr 20177:00 amRNSAnnual Financial Report & AGM
4th Apr 20177:01 amRNS2017 Q1 Trading Update
4th Apr 20177:00 amRNSFinal statement of results - year ended 31.12.16
30th Mar 201711:45 amRNSHolding(s) in Company
29th Mar 201711:33 amRNSResult of General Meeting
13th Mar 20176:07 pmRNSPosting of Circular
10th Mar 201711:06 amRNSConfirmation of successful £10 million fundraise
10th Mar 20177:15 amRNSClose of accelerated bookbuild
9th Mar 20175:03 pmRNSProposed Accelerated Bookbuild
6th Feb 20174:23 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSTrading, Acquisition, Strategy & Notice of Results
20th Jan 20177:00 amRNSAppointment of Joint Corporate Broker
8th Nov 20167:00 amRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSHolding(s) in Company
13th Sep 20167:00 amRNS2016 HALF-YEAR REPORT - SIX MONTHS TO 30 JUNE
2nd Aug 20167:00 amRNSAcquisition, Trading Update & Notice of HY Results
30th Jun 201611:54 amRNSFlowtech-winner at 2016 Regional Business Awards
2nd Jun 20167:00 amRNSGrants under the Management Incentive Plan
1st Jun 20161:40 pmRNSResult of AGM
1st Jun 20167:00 amRNSANNUAL GENERAL MEETING - TRADING UPDATE
27th May 20167:00 amRNSHolding(s) in Company
13th May 201611:51 amRNSDirector/PDMR Shareholding
6th May 20161:59 pmRNSHolding(s) in Company
3rd May 20165:23 pmRNS2015 Annual Financial Report & Notice of AGM
12th Apr 20169:10 amRNS2015 Final results - Replacement
6th Apr 201610:31 amRNSAdoption of Financial Reporting Standard (FRS) 101
26th Feb 20161:18 pmRNSHolding(s) in Company
21st Jan 20166:04 pmRNSHolding(s) in Company
19th Jan 20164:36 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update & Notice of Annual Results
21st Dec 20157:00 amRNSHolding(s) in Company
3rd Dec 20154:11 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSShare Purchases by Directors
5th Nov 20157:00 amRNSHolding(s) in Company
4th Nov 201510:09 amRNSHolding(s) in Company
3rd Nov 20157:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20157:00 amRNSHolding(s) in Company
29th Oct 20157:13 amRNSDirector Declaration
23rd Oct 20157:00 amRNSDirectorate Change
16th Sep 20158:05 amRNSDirector's Dealings
8th Sep 20157:01 amRNSEaton - Master Trading Agreement
8th Sep 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.